Stock listing

Euronext:BIM bioMerieux SA Action

Home listing (Euronext) of bioMerieux SA

Follow bioMerieux SA into a list and get an email when it puts out news.

Share price · EURONEXT:BIM

€87.25 EUR -0.35 (-0.4%)

Close on Oct 16, 2026

Since Jul 6, 2026 +25.4% · daily closes, Jul 6, 2026 – Oct 16, 2026, adjusted for splits
Day range
€86.70 – €87.95 EUROct 16, 2026
Volume
262,564 sharesOct 16, 2026
Market value
€10.27B EURAt the close on Oct 16, 2026 · price × 117.7M shares outstanding
bioMerieux SA logo
Ticker
Euronext:BIM
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Euronext
Currency
EUR

What changed lately

Calls

Replays

  • Biomerieux (Euronext:BIM) Q2 2026 Earnings Call

    Tue, Jul 28, 2026 · 8:00 AM ET

    Watch Transcript

  • Biomerieux (Euronext:BIM) Q4 2025 Earnings Call

    Fri, Feb 27, 2026 · 8:30 AM ET

    Watch Transcript

  • Biomerieux (Euronext:BIM) Q2 2025 Earnings Call

    Thu, Sep 04, 2025 · 8:00 AM ET

    Watch Transcript

Latest news

WHO Grants Emergency Use Listing for BIOFIRE Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response

Oct 19, 2026

Septembre 2026 - Déclaration sur le nombre d\'actions composant le capital social et sur le nombre de droits de vote correspondant

Oct 1, 2026

bioMerieux: BioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

Sep 16, 2026

bioMérieux Highlights Positive Impacts of Rapid, Accurate Diagnostics for Patients and Accepts Industry Awards at ADLM 2026

Aug 7, 2026

BioMérieux – First-Half 2026 Results

Jul 28, 2026

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry

Jun 18, 2026

AG 2026 - 2025 Parent company financial statements

May 4, 2026

AG 2026 - 2025 Consolidated financial statements

May 4, 2026

AG 2026 - Statutory auditors' report - 2025 Parent company annual financial statements

May 4, 2026

AG 2026 - Statutory auditors' report - 2025 consolidated financial statements

May 4, 2026

All bioMerieux SA news

Decks

bioMerieux SA on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 19 in all · newest Oct 19, 2026 · oldest 2025
Calls
5 calls with a replay · 5 with a transcript · latest Jul 28, 2026
Decks
24 decks · latest Jul 28, 2026

Where bioMerieux SA is listed

ListingExchangeCountryCurrency
Euronext:BIM · Home listing · This pageEuronextFranceEUR
OTC:BMXMFOTCUnited StatesUSD
gettex:EYWNgettexGermanyEUR
LSIN:0RUGLSINUnited KingdomEUR
OTC:BMXXYOTCUnited StatesUSD
Lang & Schwarz:A2DXZHLang & SchwarzGermanyEUR
Tradegate:EYWNTradegateGermanyEUR
LS Exchange:A2DXZHLS ExchangeGermanyEUR
Aquis:BIMPAquisUnited KingdomEUR
VIE:BIMViennaAustriaEUR
Frankfurt:EYWNFrankfurtGermanyEUR
Aquis:BIMPAquisUnited KingdomEUR
Dusseldorf:EYWNDusseldorfGermanyEUR
Turquoise:BIMPTurquoiseUnited KingdomEUR
Hamburg:EYWNHamburgGermanyEUR
Stuttgart:EYWNStuttgartGermanyEUR
BIVA:BIMXNBIVAMexicoMXN
BMV:BIMXNBMVMexicoMXN
Hanover:EYWNHanoverGermanyEUR
Munich:EYWNMunichGermanyEUR

Log in to ask 6ix AI your own questions about bioMerieux SA.